The Influence of an E-learning Program on Recognition of Actinic Keratosis
NCT05987553 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 32
Last updated 2025-04-04
Summary
The evaluation on the diagnostic accuracy of actinic keratosis recognition by general practitioners before and after participation on an e-learning program.
Conditions
- Actinic Keratoses
- E-learning
- Dermatology
Interventions
- OTHER
-
e-learning program
All participants participate in this intervention: an e-learning program about the recognition of actinic keratosis. The program exists of 30 cases. Each case exists of a question and thorough explanation including references to various sources.
Sponsors & Collaborators
-
Maastricht University Medical Center
lead OTHER
Principal Investigators
-
Klara Mosterd, prof.dr. · Maastricht UMC+
Eligibility
- Min Age
- 18 Years
- Max Age
- 67 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-01-01
- Primary Completion
- 2024-01-01
- Completion
- 2025-12-01
Countries
- Netherlands
Study Locations
More Related Trials
-
Comparative Study of Photodynamic Therapy vs. CO2 Laser Therapy in Treatment of Actinic Keratoses
NCT01481155 ·Status: UNKNOWN ·Phase: NA
-
Assessment of Treatment Success and Quality of Life in Patients With Actinic Keratoses Under Therapy With Ingenol Mebutate in a Period of 8 Weeks
NCT02090465 ·Status: COMPLETED
-
A Photodynamic Therapy for Treatment of Actinic Keratoses
NCT00558688 ·Status: COMPLETED ·Phase: NA
-
OCT and Invasion in Cutaneous Skin Lesions
NCT06014697 ·Status: COMPLETED
-
A Long Term Follow up Study of Patients Who Have Complete Clearance of Their Actinic Keratosis (AK) Lesions at the Day 57 Visit in the PEP005-028 Study
NCT00989313 ·Status: COMPLETED
-
PD P 506 A-PDT Versus Placebo-PDT and Cryosurgery for the Treatment of AK
NCT00308867 ·Status: COMPLETED ·Phase: PHASE3
-
UV Sensor in Patients With Actinic Keratosis
NCT05481073 ·Status: COMPLETED
-
Patient and Clinician Reported Outcomes for Tirbanibulin Effectiveness and Safety in Actinic Keratosis
NCT05260073 ·Status: COMPLETED
-
Photodynamic Therapy of Actinic Keratosis of the Face and Scalp With and Without Prior Curettage
NCT03697590 ·Status: COMPLETED ·Phase: PHASE4
-
Open Uncontrolled Validation Study for the German Version of the Actinic Keratosis Quality of Life Questionnaire (AKQoL)
NCT02325661 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Responsiveness of Investigator Global Assessment Score for Keratosis Pilaris
NCT06032078 ·Status: UNKNOWN ·Phase: NA
-
A Multi-Center Study to Evaluate the Efficacy and Safety of KX01 Ointment 1% on Actinic Keratosis on Face or Scalp
NCT05231044 ·Status: COMPLETED ·Phase: PHASE3
-
Microwave Treatment for Actinic Keratosis
NCT05636800 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Safety and Efficacy Study of AM001 Cream in the Treatment of Actinic Keratosis
NCT03210740 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of Tirbanibulin Ointment in Adult Participants With Actinic Keratosis
NCT06135415 ·Status: COMPLETED ·Phase: PHASE3
-
Investigation of the Efficacy and Tolerability of Topical Applied Tirbanibulin on Actinic Keratoses With Downward-directed Proliferation Patterns
NCT06648447 ·Status: RECRUITING
-
Clinical Study Assessment of SR-T100 Topical Gel Against Actinic Keratosis
NCT02085395 ·Status: COMPLETED ·Phase: PHASE2
-
Study on the Efficacy of LAS41005 in the Treatment of Actinic Keratosis
NCT00987246 ·Status: COMPLETED ·Phase: PHASE3
-
Imiquimod and Actinic Keratoses: an Observational Study
NCT01151956 ·Status: COMPLETED
-
The Real Life Topical Field Treatment of Actinic Keratosis Study
NCT02362152 ·Status: COMPLETED
-
Actinic Keratosis Study
NCT02019355 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Oral Isotretinoin Versus Topical Tretinoin for Actinic Keratosis
NCT02278861 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Phase II Study of SR-T100 to Treat Actinic Keratosis
NCT01516515 ·Status: COMPLETED ·Phase: PHASE2
-
Histological Confirmation of Clinical Clearance of Actinic Keratoses Following Treatment With Ingenol Mebutate Gel, 0.05%
NCT01892137 ·Status: COMPLETED ·Phase: PHASE1
-
Multiple-dose Pharmacokinetic Study of Solamargine in Patients With Actinic Keratosis
NCT02559934 ·Status: COMPLETED ·Phase: PHASE1